Context Therapeutics Inc is trading at $1.73, up 13.8% in after-hours trading, with no clear fundamental catalyst identified to explain the price action.
- The stock closed the regular June 9 session at $1.52 before the move occurred.
- No new company-specific filings, press releases, trial updates, or analyst actions were reported on June 9.
- The gain likely reflects thin after-hours liquidity and shifting risk sentiment rather than a disclosed fundamental catalyst.